Biodesix, Inc. Common Stock (BDSX) is a publicly traded Healthcare sector company. As of May 21, 2026, BDSX trades at $14.37 with a market cap of $144.05M and a P/E ratio of -3.06. BDSX moved +2.33% today. Year to date, BDSX is +130.66%; over the trailing twelve months it is +165.32%. Its 52-week range spans $3.44 to $36.00. Analyst consensus is strong buy with an average price target of $30.67. Rallies surfaces BDSX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Biodesix, Inc. Common Stock (BDSX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BDSX moved +2.33% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $14.37 |
| Market Cap | $144.05M |
| P/E Ratio | -3.06 |
| EPS | $-4.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $36.00 |
| 52-Week Low | $3.44 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $88.50M |
| Net Income | $-35.27M |
| Gross Margin | 0.00% |
5 analysts cover BDSX: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $30.67.